19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
IRVINE, Calif. - Edwards Lifesciences Corp., which makes heart valves and other cardiovascular products, raised its full-year profit outlook Tuesday after it reported better-than-expected second-quarter financial results.
| EW | 48.59 |  3.59 |
The company boosted full-year guidance by 5 cents per share to between $2.50 and $2.58 per share, while tightening its revenue outlook by $25 million to between $1.24 billion and $1.28 billion.
Analysts polled by Thomson Financial expect profit of $2.50 per share on revenue of $1.23 billion.
In the third quarter, the company expects profit between 53 cents and 57 cents per share, while analysts forecast 56 cents per share.
Shares of Edwards Lifesciences rose 10 cents to close at $65.25.
The Internet giant is opting for 'smaller team-focused parties'
As more Americans rely on charity amid worsening economic gloom, operators of fo...
Betty James, who co-founded the company that made the Slinky and beat the odds as a single mother in the late 1950s to become a successful execut...
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
